An Efficient and Cost-Effective Approach to Generate Functional Human Inducible Pluripotent Stem Cell-Derived Astrocytes

Cells. 2023 Sep 26;12(19):2357. doi: 10.3390/cells12192357.

Abstract

Human inducible pluripotent stem cell (hiPSC)-derived astrocytes (iAs) are critical to study astrocytes in health and disease. They provide several advantages over human fetal astrocytes in research, which include consistency, availability, disease modeling, customization, and ethical considerations. The generation of iAs is hampered by the requirement of Matrigel matrix coating for survival and proliferation. We provide a protocol demonstrating that human iAs cultured in the absence of Matrigel are viable and proliferative. Further, through a side-by-side comparison of cultures with and without Matrigel, we show significant similarities in astrocyte-specific profiling, including morphology (shape and structure), phenotype (cell-specific markers), genotype (transcriptional expression), metabolic (respiration), and functional aspects (glutamate uptake and cytokine response). In addition, we report that, unlike other CNS cell types, such as neuronal progenitor cells and neurons, iAs can withstand the absence of Matrigel coating. Our study demonstrates that Matrigel is dispensable for the culture of human iPSC-derived astrocytes, facilitating an easy, streamlined, and cost-effective method of generating these cells.

Keywords: NPC; astrocytes; glutamate uptake; iAs; iPSC; matrigel; seahorse.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Astrocytes* / metabolism
  • Cell Differentiation / genetics
  • Cells, Cultured
  • Cost-Benefit Analysis
  • Humans
  • Induced Pluripotent Stem Cells* / metabolism